Fundraising Fox

Somite

Delaware corporation · 4 known investors

somite.ai ↗

Cellular Intelligence is a cell therapy company developing engineered cell treatments for diseases, including a Phase 2-ready therapy for Parkinson's disease acquired from Novo Nordisk. The company applies computational biology and synthetic biology approaches to reprogram cellular function.

AI & Machine LearningBiotechDeep Techin /cellular-intelligence@CellularIntelHQ

Founders & leadership

MB
Micha Breakstone, Ph.D.CEO & co-founder
AK
Allon Klein, Ph.D.Scientific Co-founder
OP
Olivier Pourquié, Ph.D.Scientific Co-founder
CT
Cliff Tabin, Ph.D.Scientific Co-founder
JS
Jay Shendure, M.D., Ph.D.Scientific Co-founder
SH
Steven HoltzmanDirector
CC
Chad CowanDirector
MB
Micah BreakstoneExecutive Officer, Director, Promoter

Investors · 4

Khosla VenturesMenlo Park · $5K – $50M
Next Coast VenturesAustin · $2M – $4M
FusionreportedPalo Alto · $500K – $1M
Montage VenturesreportedMenlo Park · $4M

Reported raises · per SEC filings

Form D private placements
▶$47.5MraisedNov 2025 · 30 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven HoltzmanDirector
  • Chad CowanDirector
  • Micah BreakstoneExecutive Officer, Director, Promoter
Offering amount
$47.5M
Amount sold
$47.5M
First sale
Apr 2025
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news